Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

Pain, Postoperative Clinical Trial

Official title:

Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05549492
• Other study ID #: Nirvana Ahmed 01
• Status: Completed
• Phase: Phase 1
• Start date: January 1, 2021
• Est. completion date: May 30, 2022

Study information

• Verified date: September 2022
• Source: Egymedicalpedia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Buprenorphine intravenous, sublingual, and transdermal patches have been researched for their antihyperalgesic effects, although peripherally mediated effects have not been examined in Egypt surprisingly

Description:

This prospective, randomized, double-blind controlled trial involved 88 patients who were scheduled for inguinal hernia surgery followed by a TAP block. Patients were allocated into group B (n= 44) received 20 ml of 0.25% Ropivacaine for TAP block; group BR (n= 44) received 20 ml of 0.25% Ropivacaine containing 300 μg of buprenorphine for TAP Block. The primary outcome of the study was the analgesic and antihyperalgesic effect of buprenorphine compared to the control group. The duration of analgesia, analgesic consumption, postoperative pain scores at rest and sitting up to 48 hrs, and effect on wound hyperalgesia at 24 and 48 hrs were evaluated. Secondary outcomes of the study include incidence of side effects and TAP block-related complications were recorded. Effect of buprenorphine on patients with predicted high pain scores and incidence of persistent postoperative pain were also determined.

A transversus abdominis plane (TAP) block provides analgesia of the anterior and lateral abdominal wall below the umbilicus by blocking the T6-L1 segmental nerves as they lie within the fascial plane between the transversus abdominis and internal oblique muscles: bilateral block for midline abdominal incision. It was first described in 2001 by Rafi as a traditional blind landmark technique using the lumbar triangle of Petit. Local anesthetic is then injected between the internal oblique and transverse abdominis muscles just deep the fascial plane, the plane through which the sensory nerves pass

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: May 30, 2022
• Est. primary completion date: May 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 45 Years

Eligibility

Inclusion Criteria:

1. Patients with Inguinal Hernia

2. Medically free

Exclusion Criteria:

1. participants with a history of heart, renal and liver cell failure.

2. allergic reaction to studied drugs, and history of epilepsy,

3. hydrodynamic instability,

4. chronic pain.

5. mental illness.

Related Conditions & MeSH terms

• Hernia
• Hernia, Inguinal
• Inguinal Hernia
• Pain, Postoperative

Intervention

Drug:
• Ropivacaine 0.25%-NaCl 0.9% Injectable Solution
The pain level of the cases is evaluated by means of the digital pain (numeric rating) scale from 0 to 10 in which 0 means "no pain" and 10 means "the worst pain" as well as the duration of pain relief and the need for another dose of the same analgesic or other. The pain level is evaluated again if it is present.

Locations

Country	Name	City	State
Egypt	October 6 University Hospital	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Egymedicalpedia

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Post Operative Pain	The pain level of the cases is evaluated by means of the digital pain as the 11-point visual analog scale (VAS) whereas 0-Represents no pain, 10 - Worst imaginable pain), as well as the 11-point VAS-A (0-Represents no anxiety, 10 - Highest anxiety)	2 hours after the operation upto 48-hour analgesic after surgery